Immediate Impact
1 from Science/Nature 64 hit
Citing Papers
Hepatocellular carcinoma: signaling pathways and therapeutic advances
2025 Hit
Lactate: A key regulator of the immune response
2025 Hit
Works of Tian‐En Li being referenced
Inhibition of EGFR Overcomes Acquired Lenvatinib Resistance Driven by STAT3–ABCB1 Signaling in Hepatocellular Carcinoma
2022
Driver mutations of intrahepatic cholangiocarcinoma shape clinically relevant genomic clusters with distinct molecular features and therapeutic vulnerabilities
2021